Novozymes to Buy Merck KGaA's Crop BioScience Business for $275 Million

Enzymes technology firm Novozymes has agreed to buy Merck KGaA’s (Darmstadt, Germany) Crop BioScience business for $275 million. The firm’s say they expect to complete the transaction at the beginning of 2011.   The deal makes Novozymes “a major player in sustainable solutions for the agricultural biologicals industry,” Novozymes says.   Merck’s Crop BioScience business researches, develops and commercializes technologies used to improve plant health and crop yields. The business’s activities are carried out in North...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers